Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2 - Concepedia

Concepedia

Publication | Open Access

Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2

DOI Full Paper Access

36

Citations

21

References

2020

Year

Ikumi Kuriwaki, Minoru Kameda, Hiroyuki Hisamichi, Shigetoshi Kikuchi, Kazuhiko Iikubo, Yuichiro Kawamoto, Hiroyuki Moritomo, Yutaka Kondoh, Y. Amano, Y. Tateishi,

Bioorganic & Medicinal Chemistry

Medicinal ChemistryPharmaceutical ScienceMedicineDrug DiscoveryNatural SciencesHigh SelectivityStructure-based Drug DesignRational Drug DesignNovel Fgfr3 InhibitorsPharmacotherapyAnti-cancer AgentDrug DevelopmentChemical BiologyPharmacologyMolecular ModelingPharmaceutical ChemistryBiomolecular Engineering

References

	Year	Citations

Page 1

Page 1